Highlights
– ESC sees SHIFT in heart failure treatment
– FDA advisory committe recommends approval of tricagrelor for acute coronary syndromes
– Interview – George Dangas
– New Jupiter analysis
Highlights
– ESC sees SHIFT in heart failure treatment
– FDA advisory committe recommends approval of tricagrelor for acute coronary syndromes
– Interview – George Dangas
– New Jupiter analysis